QuickView for inositol 1,4,5 trisphosphate binding (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
5. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens

1. Protein phosphatase regulation by PRIP, a PLC-related catalytically inactive protein--implications i…
2. Characterization of the human PRIP-1 gene structure and transcriptional regulation.
3. The inhibition of [³H] inositol 1,4,5-trisphosphate binding by Ca²⁺ is modified after long-term etha…
4. Pharmacological characterization of inositol-1,4,5,-trisphosphate binding to membranes from retina a…
5. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisph…

There were no clinical trials for inositol 1,4,5 trisphosphate binding